GGrantIndex
← Leaderboards

University Of California Los Angeles

Los Angeles, CA

Compare ↔
$10,534,045,050
Total funding
9,174
Grants

Funding over time

peak $722.4M · FY2005–25
$1B$750M$500M$250M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25

Funding mix

By agency

NIH$10,393,968,610 · 9042
CDC$109,151,099 · 49
AHRQ$37,604,577 · 71
FDA$4,329,742 · 6
ACF$25,000 · 1
SAMHSA$0 · 7

By mechanism

R01$4,722,453,101 · 2359
UM1$985,489,639 · 6
U01$757,113,716 · 178
P01$414,545,873 · 371
T32$338,986,316 · 102
R21$314,070,931 · 799

Investigators at University Of California Los Angeles

Investigator-initiatedAll funding

InvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Exposure= the full size of every grant they're on ($1M each).

Rising Stars

First grant in the last 5 yrs

1Alexander Thomas Ian Strudwick Young$3,108,1282 gr2Chao Peng$2,935,0942 gr3Melissa Sharpe$2,552,8983 gr4May Sudhinaraset$2,456,3321 gr5Catherine M Cahill$2,256,9591 gr6Lindsay Mitchell De Biase$1,595,0941 gr7Yongjie Hu$1,560,0001 gr8Daniel M Beswick$1,361,4161 gr

Emerging Leaders

6–10 yrs in

1Weizhe Hong$10,505,1895 gr2Hae Lin Jang$8,327,3525 gr3Yusuke Tsugawa$8,030,8163 gr4Jonathan Flint$7,990,6823 gr5Maxime Cannesson$7,714,3673 gr6Loes Marlein Olde Loohuis$6,905,0954 gr7Carlos Lopez Jaramillo$6,456,3683 gr8Liang Gao$6,317,3546 gr

All-Time

Most funded here, all years

1Daniel H Geschwind$79,256,28016 gr2Robert L Modlin$43,521,38013 gr3Cun-Yu Wang$42,747,30519 gr4Kevin A. Pelphrey$36,823,7268 gr5Paul M Thompson$34,679,39330 gr6Nelson B Freimer$31,848,86215 gr7Mary J Rotheram-Borus$31,647,96113 gr8Jack L. Feldman$29,741,76213 gr

Largest grants

Leadership and Operations Center (LOC), AIDS Clinical Trials Group (ACTG); LOC 1/$181,942,638
UM1 · FY2020 · AI
AIDS Clinical Trials Group for Research on Therapeutics for HIV and Related Infections$76,222,582
UM1 · FY2023 · AI
Leadership and Operations Center (LOC), AIDS Clinical Trials Group (ACTG); LOC 1/$71,500,000
UM1 · FY2022 · AI
AIDS Clinical Trials Group for Research on Therapeutics for HIV and Related Infections$44,503,132
UM1 · FY2021 · AI
AIDS Clinical Trials Group for Research on Therapeutics for HIV and Related Infections$40,164,858
UM1 · FY2021 · AI
AIDS Clinical Trials Group for Research on Therapeutics for HIV and Related Infections$39,807,800
UM1 · FY2023 · AI
Advancing Clinical Therapeutics Globally for HIV/AIDS and Other Infections$38,497,989
UM1 · FY2024 · AI
AIDS Clinical Trials Group for Research on Therapeutics for HIV and Related Infections$37,136,690
UM1 · FY2022 · AI
Advancing Clinical Therapeutics Globally for HIV/AIDS and Other Infections$36,436,959
UM1 · FY2025 · AI
Leadership and Operations Center (LOC), AIDS Clinical Trials Group (ACTG); LOC 1/$36,091,763
UM1 · FY2020 · AI
Leadership and Operations Center (LOC), AIDS Clinical Trials Group (ACTG); LOC 1/$32,273,937
UM1 · FY2019 · AI
AIDS Malignancy Consortium (AMC)$23,766,226
UM1 · FY2018 · CA
AIDS Malignancy Consortium (AMC)$23,267,256
UM1 · FY2017 · CA
AIDS Malignancy Consortium (AMC)$21,619,997
UM1 · FY2016 · CA
AIDS Clinical Trials Group for Research on Therapeutics for HIV and Related Infections$20,566,378
UM1 · FY2021 · AI
CoVPN 3502 / ACTIV-2/A5401$19,807,516
UM1 · FY2021 · AI
AIDS Malignancy Consortium (AMC)$17,451,533
UM1 · FY2019 · CA
A5418 MPX-TPOXX Study Supplement$17,327,975
UM1 · FY2022 · AI
UCLA Clinical and Translational Science Institute$15,457,370
UL1 · FY2011 · RR
UCLA Clinical and Translational Science Institute$15,079,371
UL1 · FY2012 · TR